Berkovich

TrueMed Therapeutics is an Israel-based specialty pharmaceutical company focused on the distribution and commercialization of innovative therapies for rare and niche diseases. Founded in 2015, the company serves as a strategic partner for global pharmaceutical and biotech firms seeking to enter the Israeli and regional markets. TrueMed provides a comprehensive suite of services, including regulatory registration, market access, medical affairs, and specialized logistics. By bridging the gap between global innovators and local patients, the company ensures that life-saving treatments for orphan conditions reach those in need. Its portfolio encompasses a diverse range of therapeutic areas, with a particular emphasis on high-unmet-need medical sectors.